Literature DB >> 19117032

Nip2/centrobin may be a substrate of Nek2 that is required for proper spindle assembly during mitosis in early mouse embryos.

Seongkeun Sonn1, Yeontae Jeong, Kunsoo Rhee.   

Abstract

Nek2 is a mitotic kinase with multiple cellular functions involving phosphorylation of diverse substrates. Suppression of Nek2 in early mouse embryos has been shown to arrest development at the 4-cell stage with defects in mitotic spindle assembly as well as in interphase nuclear morphology. In the present study, we suppressed expression of two Nek2 centrosomal substrates, Nip2 and C-Nap1, in early mouse embryos. The development of the Nip2-suppressed embryo was arrested at the 4-cell stage with mitotic defects in the blastomeres. In contrast, C-Nap1 suppression did not produce a visible phenotype. The phenotypic similarities of the Nip2- and Nek2-suppressed embryos suggest that Nip2 may be a substrate of Nek2 that is required for mitotic spindle assembly in early mouse embryos.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117032     DOI: 10.1002/mrd.20990

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  8 in total

Review 1.  Targeting NEK2 as a promising therapeutic approach for cancer treatment.

Authors:  Yanfen Fang; Xiongwen Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Centrobin/NIP2 is a microtubule stabilizer whose activity is enhanced by PLK1 phosphorylation during mitosis.

Authors:  Jungmin Lee; Yeontae Jeong; Saimi Jeong; Kunsoo Rhee
Journal:  J Biol Chem       Date:  2010-05-29       Impact factor: 5.157

Review 3.  TRIM37: a critical orchestrator of centrosome function.

Authors:  Andrés Domínguez-Calvo; Pierre Gönczy; Andrew J Holland; Fernando R Balestra
Journal:  Cell Cycle       Date:  2021-10-21       Impact factor: 5.173

4.  NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Authors:  Wen Zhou; Ye Yang; Jiliang Xia; He Wang; Mohamed E Salama; Wei Xiong; Hongwei Xu; Shashirekha Shetty; Tiehua Chen; Zhaoyang Zeng; Lei Shi; Maurizio Zangari; Rodney Miles; David Bearss; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

5.  Rat hd mutation reveals an essential role of centrobin in spermatid head shaping and assembly of the head-tail coupling apparatus.

Authors:  Frantisek Liska; Claudia Gosele; Eugene Rivkin; Laura Tres; M Cristina Cardoso; Petra Domaing; Eliska Krejcí; Pavel Snajdr; Min Ae Lee-Kirsch; Dirk G de Rooij; Dirk G de Rooij; Vladimír Kren; Drahomíra Krenová; Abraham L Kierszenbaum; Norbert Hubner
Journal:  Biol Reprod       Date:  2009-08-26       Impact factor: 4.285

Review 6.  Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition.

Authors:  Brendan Frett; Robert V Brown; Mingliang Ma; Wenhao Hu; Haiyong Han; Hong-yu Li
Journal:  J Med Chem       Date:  2014-02-25       Impact factor: 7.446

7.  Nek family of kinases in cell cycle, checkpoint control and cancer.

Authors:  Larissa Moniz; Previn Dutt; Nasir Haider; Vuk Stambolic
Journal:  Cell Div       Date:  2011-10-31       Impact factor: 5.130

Review 8.  Role of NEK2A in human cancer and its therapeutic potentials.

Authors:  Jiliang Xia; Reinaldo Franqui Machin; Zhimin Gu; Fenghuang Zhan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.